loader image
COVID19 UPDATES
Slide
Slide
Slide 1
previous arrow
next arrow

Our Services

For Products and Establishments registration at FDA

Verification Portal

Check the List of Approved FDA
Authorizations

eServices Portal

New Online Application System for FDA Authorizations

ePortal System

Apply and Register for License to Operate, Certificate of Product Registration, and other FDA Authorizations

ePortal v.2 System

Authorizations for HUHS and Novel Tobacco Products

COVID19-related Updates

(Click Logo below for Updates)

Latest Advisories

FDA Advisory No.2022-0005 || Public Health Warning Against the Alleged Rampant Selling of Molnupiravir in the Market

The Food and Drug Administration (FDA) warns all healthcare professionals and the public on significant risks associated with the growing...
Read More

FDA Advisory No.2021-3641-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong...
Read More

FDA Advisory No.2021-3641 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:

The Food and Drug Administration (FDA) advises the public against the purchase and use of the following unregistered drug products:...
Read More

FDA Advisory No.2021-3611-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot na “Firstaid Caring for Life Antiseptic Povidone-Iodine Prep Pads Medium 100’s”

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili atpaggamit ng hindi rehistradong gamot na: Napatunayan sa...
Read More

FDA Advisory No.2021-3611 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Firstaid Caring for Life Antiseptic Povidone-Iodine Prep Pads Medium 100’s”

The Food and Drug Administration (FDA) advises the public against the purchase and use of the unregistered drug product: Firstaid...
Read More

FDA Advisory No.2021-3610-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot na “Benzalkonium Chloride (Benzellin) 0.13% Tincture 5 mL”

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng hindi rehistradong gamot na: Benzalkonium...
Read More

FDA Advisory No.2021-3610 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Benzalkonium Chloride (Benzellin) 0.13% Tincture 5 mL”

The Food and Drug Administration (FDA) advises the public against the purchase and use of the unregistered drug product: Benzalkonium...
Read More

FDA Advisory No.2021-3609-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot na “Veko Lactic Acid and Salicylic Acid CL-EarTM Cleanser 100 mL”

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng hindi rehistradong gamot na: Veko...
Read More

FDA Advisory No.2021-3609 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Veko Lactic Acid and Salicylic Acid CL-EarTM Cleanser 100 mL”

The Food and Drug Administration (FDA) advises the public against the purchase and use of the unregistered drug product: FDA...
Read More

FDA Advisory No.2022-0006 || UPDATED LIST OF DRUG PRODUCTS UNDER EMERGENCY USE (DEU) FOR COVID-19

Under FDA Circular 2021-008 or the Updated Guidelines for the Registration of Drug Products Under Emergency Use (DEU) for COVID-19,...
Read More

Announcement

Seminar Venue for CDRR QPIRA Seminar on 26-27 July 2018
Please be informed that the conduct of CDRR QPIRA Seminar on 26-27 July 2018, shall be held at The Bellevue ...
Read More
Cloud Migration
Please be advised that ICTMD will conduct migration activity (from FDA Server to  Cloud System) starting today 13-July- 2018, from ...
Read More
Seminar Venue for QPIRA CFRR in Cebu CIty on 12-13 July 2018
Please be informed that the QPIRA for Center for Food Regulation and Research (CFRR) Seminar scheduled on 12-13 July 2018 ...
Read More